Ticagrelor breaks up the tumor-platelet party

Annachiara Mitrugno, Owen McCarty

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Abstract

In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1

Original languageEnglish (US)
Pages (from-to)1177-1178
Number of pages2
JournalBlood
Volume130
Issue number10
DOIs
StatePublished - Sep 7 2017

Fingerprint

Diphosphates
Primary Prevention
Secondary Prevention
Platelets
Ovarian Neoplasms
Adenosine
Adenosine Diphosphate
Tumors
Blood
Blood Platelets
Cells
Growth
Neoplasms
Therapeutics
Ticagrelor

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Ticagrelor breaks up the tumor-platelet party. / Mitrugno, Annachiara; McCarty, Owen.

In: Blood, Vol. 130, No. 10, 07.09.2017, p. 1177-1178.

Research output: Contribution to journalComment/debate

Mitrugno, Annachiara ; McCarty, Owen. / Ticagrelor breaks up the tumor-platelet party. In: Blood. 2017 ; Vol. 130, No. 10. pp. 1177-1178.
@article{14696276a8b3460dbc4295fff0ccd764,
title = "Ticagrelor breaks up the tumor-platelet party",
abstract = "In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1",
author = "Annachiara Mitrugno and Owen McCarty",
year = "2017",
month = "9",
day = "7",
doi = "10.1182/blood-2017-07-795898",
language = "English (US)",
volume = "130",
pages = "1177--1178",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - Ticagrelor breaks up the tumor-platelet party

AU - Mitrugno, Annachiara

AU - McCarty, Owen

PY - 2017/9/7

Y1 - 2017/9/7

N2 - In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1

AB - In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1

UR - http://www.scopus.com/inward/record.url?scp=85029232011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029232011&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-07-795898

DO - 10.1182/blood-2017-07-795898

M3 - Comment/debate

C2 - 28882833

AN - SCOPUS:85029232011

VL - 130

SP - 1177

EP - 1178

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -